| Literature DB >> 33013245 |
Friedrich Boettner1, Mathias P Bostrom1, Mark Figgie1, Alejandro Gonzalez Della Valle1, Steven Haas1, David Mayman1, Douglas Padgett1.
Abstract
Entities:
Keywords: COVID-19; arthroplasty; elective surgery
Year: 2020 PMID: 33013245 PMCID: PMC7524030 DOI: 10.1007/s11420-020-09801-4
Source DB: PubMed Journal: HSS J ISSN: 1556-3316
Classification of essential and elective surgeries
| Category | General description | Arthroplasty surgery | |
|---|---|---|---|
| Essential | Emergent | Need for immediate care. Delay can be life- of limb-threatening or result in long term functional disability. | THA for hip fracture, peri-prosthetic fracture, prosthetic joint infection, catastrophic mechanical failure of implant, manipulation under anesthesia, evacuation of hematoma. |
| Urgent | Condition that if left untreated can result in sub-optimal outcome, aggravation of underlying medical condition, or chronic opioid dependence. | Pending peri-prosthetic fracture, some prosthetic joint infection, recurrent dislocation, advanced osteonecrosis with collapse and bone loss, rapidly progressive OA, some reimplantation. | |
| Priority | Condition that if left untreated will result in sub-optimal outcome for a variety of medical or socioeconomic factors | Some primary and revision arthroplasty, some revisions and reimplantation. | |
| Elective | Low risk | Procedure that will improve patient’s function. There is no time constraint on its optimal outcome. Low-risk patients only. | Elective primary and revision arthroplasty. Single stage bilateral arthroplasty. |
| All patients | Procedure that will improve patient’s function. There is no time constraint on its optimal outcome. Low-risk patients only. | Elective arthroplasty. | |
Risk stratification for patients undergoing surgery
| Number | |
|---|---|
| 1 | COVID-19 negative |
| 2 | Age < 70 years (later expanded to age < 60 at the end of May 2020) |
| 3 | ASA class 1 or 2 |
| 4 | Body mass index < 40 |
| 5 | Non-smoker |
| 6 | Low risk for complex pain management challenges |
| 7 | Opioid use < 6 months |
| 8 | No history of substance use disorder, including active/current licit or illicit substance abuse |
| 9 | No intrathecal pump |
| 10 | No history of or current buprenorphine use |
| 11 | No history of coronary artery disease, heart failure, valvular heart disease, pulmonary disease, immunosuppressive disease or therapy |
| 12 | Diabetes: none or HbA1c < 7 (later expanded to < 8 at the end of May 2020) |
| 13 | Chronic kidney disease class 1–2 |
| 14 | Expected hospitalization ≤ 48h |
| 15 | Not expected to need inpatient pain consult |
| 16 | Not expected to need blood transfusion |
| 17 | Independent functional status pre-operatively |
| 18 | Expected discharge to home (e.g., RAPT ≥ 9) |
| 19 | Ability to participate in remote/telerehabilitation |
RAPT Risk Assessment and Prediction Tool, ASA American Society of Anesthesiologists